secwatch.observer — SEC 8-K summary
======================================

Issuer:     Foghorn Therapeutics Inc. (FHTX)
CIK:        0001822462
Form:       8-K
Filed at:   2024-06-26T23:59:59+00:00
Accession:  0001628280-24-030137
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Foghorn Therapeutics stockholders re-elect three Class I directors, ratify Deloitte as auditor
--------------------------------------------------------------------------------

- Scott Biller elected with 20,425,665 votes for, 4,930,514 against; 5,014,629 broker non-votes.
- Thomas J. Lynch elected with 24,052,377 votes for, 1,293,218 against.
- Michael Mendelsohn elected with 22,357,558 votes for, 2,988,038 against.
- Ratification of Deloitte & Touche as auditor approved: 30,355,319 for, 10,376 against, 15,450 abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822462/000162828024030137/0001628280-24-030137-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822462/000162828024030137/fhtx-20240626.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-030137

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer